Page 5 - Healthcare Technologies

Covid-19 testing in Mumbai to take a hit after private players barred

In Delhi too, SRL Diagnostics was told to stop testing certain categories of patients at the end of May for a few days, officials say

Delhi added 10,000 coronavirus cases in eight days from June 1

Delhi reported its first case on March 1, when a businessman in East Delhi was diagnosed with Covid-19 after returning from Italy

Serum Institute risks making Covid vaccine before trial at new $100 mn unit

AstraZeneca deal with SII is for supply of a billion doses, with a commitment to provide 400 mn before 2020-end. If all goes well, India could have its first set of Covid-19 vaccines by end of year

Steep death graph, no peak yet: Why India is behind the curve on Covid-19

While the mortality rate seems to be plateauing in UK , Spain and Italy after peaking, in India he bad news is that it hasn't reached the high point after which it can start tapering off

India simplifies clinical trial rules for Covid-19 vaccine manufacturing

Govt will take inter-departmental approach to ensure right vaccine candidate is available for Indians at the earliest

Tata Group partners Trivandrum-based institute to make Covid-19 test kits

Tata Sons has now tied up with the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, under the Department of Science and Technology for commercial production

ICMR asks states to revise cost of Covid-19 test; material cost may reduce

India has reported a total number of 1,51,767 cases of coronavirus, of which 64,425 have been cured/discharged while 4,337 have lost their lives

India cancels orders for Chinese Covid-19 test kits, says won't lose money

States must stop using rapid antibody test kits procured from Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, said ICMR

Covid-19: Hamdard Labs to conduct clinical trials of immunity booster

The Ministry of AYUSH has invited inputs from Ayush practitioners and institutions including colleges, universities, hospitals, research institutes

Home healthcare sees larger role amid Covid-19, seeks insurance coverage

Covid-19 has expanded the market for home healthcare providers, enabling them to provide both at-home healthcare and remote healthcare, apart from reaching out to corporates

Oxford University Covid-19 vaccine trial has 50% chance of 'no result'

The University of Oxford last week announced that the advance human trial of the vaccine will involve up to 10,260 volunteers across the UK

4 Covid-19 vaccines may soon enter the clinical-trial stage: Harsh Vardhan

There are over 100 candidate vaccines which are at different levels of development

Everstone-backed firm CPC Diagnostics launches Covid-19 antibody tests

Depending on the analyser model, a lab can report up to 2,000 results a day on a single instrument, with flexibility for facilities to add further modules to ramp up output substantially

Covid-19 count inches closer to 100,000; highest single day spike recorded

The cases in Maharashtra saw the highest increase of 2,347, state tally stands at 33,053

Wipro unveils sanitisation walkways, robots to fight the coronavirus

Developed in four weeks, these walkways have already been installed at Wipro's campuses and factories. The walkway has been priced between Rs 1-1.3 lakh per unit

Guidelines issued for pool-testing of migrant workers, global travellers

Pool testing is a cost effective and time saving method of detecting the spread of Covid among the population

Fitch highlights India's two big challenges in fight against coronavirus

The significant inefficiency, dysfunctioning and acute shortage of the healthcare delivery systems in the public sector do not match up with the growing needs of the population, says the report

Covid-19: CSIR-NAL develops non-invasive ventilator in record 36 days

The system has undergone stringent biomedical tests and beta clinical trials at NAL Health Centre

Can Ganga water treat Covid-19? ICMR says no to study, need more data

Evidence and data available at the moment is not strong enough to start the clinical studies, said Dr Y K Gupta

Pocket-friendly innovations from IITs join India's fight against Covid-19

Institutes across the country have developed testing devices, ventilators priced at Rs 25,000 and sanitising sprays, among other things, at low-cost or on a not-for-profit basis